Zirngibl, F., Ivasko, S. M., Grunewald, L., Klaus, A., Schwiebert, S., Ruf, P., . . . Künkele, A. (2021). GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma. J Immunother Cancer.
Citação norma ChicagoZirngibl, Felix, et al. "GD2-directed Bispecific Trifunctional Antibody Outperforms Dinutuximab Beta in a Murine Model for Aggressive Metastasized Neuroblastoma." J Immunother Cancer 2021.
Citação norma MLAZirngibl, Felix, et al. "GD2-directed Bispecific Trifunctional Antibody Outperforms Dinutuximab Beta in a Murine Model for Aggressive Metastasized Neuroblastoma." J Immunother Cancer 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.